Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 794 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
The Board Meeting to be held on 29/05/2026 has been revised to 30/05/2026 The Board Meeting to be held on 29/05/2026 has been revised to 30/05/2026
Regulatory Filings Classification · 82% confidence The document is a notice to stock exchanges under SEBI Listing Obligations about the postponement and rescheduling of a Board meeting date to approve audited financial results and related compliance (trading window closure). It does not contain financial data or the report itself, nor does it announce a director change, dividend declaration, or management changes. It is a general regulatory announcement/fallback notification, best fitting the Regulatory Filings (RNS) category.
2026-05-26 English
Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Regulatory Filings Classification · 80% confidence The document is an exchange filing under SEBI LODR Regulation 29 notifying the stock exchanges of a scheduled Board meeting to consider and approve audited financial results. It does not contain actual financial statements or results, nor does it announce publication of a report; it is a general regulatory announcement/disclosure. Therefore, it falls under the catch-all Regulatory Filings category (RNS).
2026-05-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and depositories reporting the details of shares dematerialized during April 2026. It references compliance with SEBI regulations and includes a certificate from the registrar and share transfer agent confirming the dematerialized shares. The content is an official notification about share dematerialization status, not a financial report, earnings release, or management discussion. The document length is short (2841 characters) and it serves as a regulatory compliance update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-07 English
Disruption of Operations
Regulatory Filings Classification · 95% confidence The document is an official notification addressed to stock exchanges regarding a fire incident at a subsidiary's facility. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an incident disclosure with details about the event, impact, and insurance coverage. It is not a financial report, earnings release, or management discussion. It is a regulatory announcement informing the market about a material event affecting operations. The document length is 3764 characters, relatively short and focused on disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-30 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports an update on ongoing tax litigation involving the company, specifically the outcome of an Income Tax Appellate Tribunal order that affects a prior tax demand. The document includes a detailed annexure with specifics about the communication received from the tax authority, the financial year concerned, and the financial implications. There are no financial statements or comprehensive financial data presented, nor is this a full report like an annual or interim report. The document is an official regulatory announcement about a legal/tax matter affecting the company, consistent with a Regulatory Filing (RNS) rather than an Audit Report or Legal Proceedings Report since it is a regulatory disclosure under SEBI LODR. The length is about 5350 characters, which is sufficient for a detailed regulatory announcement but not a full report. Therefore, the best classification is Regulatory Filings (RNS).
2026-04-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions the enclosure of newspaper copies about a notice for investors concerning the opening of a Special Window for Transfer and Dematerialization of physical shares. The content is an official communication informing the exchanges about the publication of a notice in newspapers. There is no financial data, no detailed report, no voting results, no management discussion, or any other substantive report content. The document is essentially an announcement of a regulatory compliance action and the publication of a notice, not the notice itself or a financial report. The document length is 15,000 characters, but the content is a compliance announcement. According to the rules, such communications fall under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other categories. Therefore, the correct classification is Regulatory Filings (RNS).
2026-04-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.